4.6
48 Ratings with 9 written Reviews
Summary
Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.
Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye …Hospital in Philadelphia.
There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.
Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible.
Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network.
Read More Read less Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye …Hospital in Philadelphia.
There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.
Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible.
Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network.
Provider Video
Office Locations
Dr. Brian Peter Marr has 2 locationsCUIMC/Edward S. Harkness Eye Institute
622 W 168th Street Vanderbilt Clinic Building, 3rd FloorNew York, NY 10032Mon8:00 am - 5:00 pm
Tue8:00 am - 5:00 pm
Wed8:00 am - 5:00 pm
Thu8:00 am - 5:00 pm
Fri8:00 am - 5:00 pm
SatClosed
SunClosed
Quick Facts
- accepting new patients
- 31 years of experience
- 13 insurance plans accepted
- speaks English, Spanish
- Lewis Katz School Of Medicine At Temple University
- 9 written reviews
- 3 specialties
- 23 areas of expertise
- 3 board certifications
- 1 hospital affiliation
- 2 office locations
- Male
Patients’ Perspective
- Gave an accurate diagnosis
- Had a good bedside manner
- Spent time with me
Based on patient feedback. Read the reviews
Insurance Plans Accepted by Dr. Brian Peter Marr
Medical Specialties
Dr. Brian Peter Marr has the following 3 specialties
Specialty Expertise
Dr. Brian Peter Marr has the following 23 areas of expertise
Certifications, License, & Education
31 Years Experience
MEDICAL LICENSE
Medical Doctor, New York, 2027, Active
EDUCATION & TRAINING
Medical School
Lewis Katz School Of Medicine At Temple UniversityGraduated in 1995
Frequently Asked Questions
- Which hospitals is Dr. Brian Marr affiliated with?
- Dr. Brian Marr is affiliated with Newyork Presbyterian Columbia University Irving Medical Center.
- How can I make an appointment with Dr. Brian Marr?
- You can find contact information for Dr. Brian Marr here on Vitals.
- What languages does Dr. Brian Marr speak?
- Dr. Brian Marr speaks English and Spanish.
- Does Dr. Brian Marr accept my insurance?
- You can see the insurance plans that Dr. Brian Marr accepts on their Vitals profile.
- Is Dr. Brian Marr accepting new patients?
- Dr. Brian Marr is accepting new patients on Vitals. View Dr. Brian Marr's profile on Vitals to make an appointment.
Ensuring Data Transparency and Trust: A Guide to Vitals Doctor Listings and Reviews
Our provider data is gathered directly from physicians and publicly available databases. Providers who verify their profiles gain the ability to update information, offering additional details about their specialties,education, treated conditions, performed procedures, and accepted insurances.
Reviews on Vitals are submitted by users only. Recognizing the valuable insights these reviews offer into a doctor's reputation, we maintain internal policies and protocols to ensure the quality and accuracy of all reviews. Importantly, providers cannot delete or alter reviews independently. Reviews can only be deleted or changed following an internal assessment by our customer service team.
Your feedback is highly valued and we encourage you to contact our support team should you encounter any issues.
